Company / CapEx per Share
Jade Biosciences, Inc. CapEx per Share History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2023
5-year range
$0.01 / $0.01
FY2021-FY2023
Trend
-32.3%
vs FY2022
Sector context
#143 of 191
Health Care
What the data says
Jade Biosciences, Inc.'s capex per share of $0.01 is lower than 75% of companies in the Health Care sector (FY2023). Declined from $0.01 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2023.
Declined from $0.01 to $0.01 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 191This company $0.01 Sector average $4.05
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2023, capex per share decreased 32.3% year-over-year.
- Ranks #143 out of 191 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0.01 | -32.3% |
| FY2022 | $0.01 | -45.9% |
| FY2021 | $0.01 | - |
| FY2020 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026